Search
for
Sort by
Research 541–570 of 1000+
- Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors and baricitinib: A case report and literature review
- Expert consensus on systemic treatment activation and grading evaluation for alopecia areata
- Discovery of a novel and highly selective JAK3 inhibitor as a potent hair growth promoter
- Surgery Update for General Dermatologists Session 1
- Inhibition of JAK-STAT Signaling with Baricitinib Reduces Inflammation and Improves Cellular Homeostasis in Progeria Cells
- Saw Palmetto Extract Inhibits Metastasis and Antiangiogenesis through STAT3 Signal Pathway in Glioma Cell
- Iron Deficiency in Immune-Mediated Inflammatory Skin Diseases: A Missing Link Between Systemic Inflammation, Immunometabolism, and Disease Burden
- In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling
- In Silico Structure-Based Drug Design Approach To Evaluate Quercetin And Kaempferol As Dual Inhibitors Of Jak3 Kinase And 5-Alpha Reductase Type II with ADMET Profiling
- Drug repurposing of cyclin-dependent kinase inhibitors for neutrophilic acute respiratory distress syndrome and psoriasis
- Epigallocatechin-3-gallate inhibits paclitaxel-induced apoptosis through the alteration of microRNA expression in human dermal papilla cells
- Unraveling Translational Insights into Systemic Multi-Organ Toxicity of Cytosine Arabinoside (Ara-C): A Systematic Review of Preclinical Animal Evidence
- Treating Psoriasis: What Is New About Fumaric Acid Esters?
- European expert consensus statement on the systemic treatment of alopecia areata
- Environmental Air Pollutants Affecting Skin Functions with Systemic Implications
- Concise Review: The Plasticity of Stem Cell Niches: A General Property Behind Tissue Homeostasis and Repair
- Natural Compounds Targeting MAPK, PI3K/Akt, and JAK/STAT Signaling in Papillary Thyroid Cancer
- Development of Novel Drug Delivery Systems for the Treatment of Alopecia
- Development of Novel Drug Delivery Systems for the Treatment of Alopecia
- Skin aging: mechanisms, evaluation, and rejuvenation
- Mechanistic study of Erianin in alopecia areata
- Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report
- Case Report: Baricitinib improved alopecia areata in a pediatric patient with atopic dermatitis
- Patient preferences in the treatment of alopecia areata: A review of the literature
- Efficacy and Safety of Long‐Term Azathioprine Therapy for Severe Alopecia Areata: A 10‐Year Cohort Study
- Visualizing Severity of Alopecia Tool (SALT) scores in the clinical setting using patient images from a clinical trial
- Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata
- Oral abrocitinib for treatment of refractory alopecia areata: A retrospective study
- Successful treatment of severe diffuse alopecia areata with abrocitinib
- Application of Baricitinib in Dermatology